Semaglutide vs. Tirzepatide: Which Weight Loss Medication Is Right for You?

By Shataniel Taylor, FNP-BC · 2025-01-28 · 5 min read

If you've been researching medical weight loss, you've probably heard of Semaglutide (the active ingredient in Ozempic® and Wegovy®) and Tirzepatide (Mounjaro® and Zepbound®). Both are FDA-approved GLP-1 receptor agonists that have shown remarkable results — but they work slightly differently.

How Semaglutide Works

Semaglutide mimics GLP-1, a hormone that regulates appetite and blood sugar. It slows gastric emptying, making you feel full longer, and reduces cravings. Clinical trials showed patients losing an average of 15-17% of their body weight.

How Tirzepatide Works

Tirzepatide is a dual-action medication — it targets both GLP-1 and GIP receptors. This dual mechanism may provide enhanced weight loss and blood sugar control. In studies, patients lost up to 22% of their body weight, making it one of the most effective weight loss medications available.

Side Effects Comparison

Both medications share similar side effects, primarily gastrointestinal: - Nausea (usually temporary, improves with dose titration) - Decreased appetite - Occasional constipation or diarrhea

Tirzepatide may cause slightly more GI side effects initially, but most patients adjust within 2-4 weeks.

Cost Comparison at Crystal Body Health

Both include your monthly consultation and dose adjustments. No insurance is required.

Which One Should You Choose?

The best medication depends on your health history, weight loss goals, and how your body responds. During your initial $50 consultation at Crystal Body Health, your provider will review your complete health profile and recommend the option that's safest and most effective for you.

Start Your Weight Loss Journey

Don't let confusion about medications hold you back. Schedule a consultation today and get personalized guidance from a board-certified provider.